We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Chemical Can Induce Nerve Growth after Stroke

By Biotechdaily staff writers
Posted on 09 Jul 2002
An animal study has shown that inosine, a naturally occurring chemical, can induce axon growth within the brain and spinal cord, thereby improving motor function after a stroke.
The study was published in the June 25, 2002, issue of the Proceedings of the National Academy of Sciences.

In the study, rats treated with inosine had nearly normal paw-placing ability after 19 days, whereas untreated rats remained 50% below normal. More...
The results of anatomical studies correlated with functional results. Inosine showed the ability to increase the capacity of nerve cells to make new connections to those brain areas that had lost their normal inputs because of a stroke. The inosine-stimulated increases were three to four times higher than in the rats not receiving inosine. There were no apparent side effects.

"The study shows that inosine induces a great deal of rewiring in the brain after stroke,” said Dr. Larry Denowitz, principal investigator and head of the laboratory at Children's Hospital (Boston, MA, USA), where much of the study was conducted. "This rewiring is apparently sufficient to promote substantial functional recovery.”

Inosine is being developed for the treatment of stroke and other central nervous system injuries by Boston Life Sciences, Inc. (BLSI, MA, USA). "Stroke has been a poorly understood and inadequately treated area of medicine,” said Dr. Marc Lanser, M.D., chief scientific officer of BLSI. "These data offer great hope that we may finally see a breakthrough in treatment that can repair the damage by stroke.”






Related Links:
Chidlren's Hosp.
BLSI

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Immunoassay Analyzer
Procise DX
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.